Hossam Gamal Zahra

*Increasing the market share of well established Zoladex & Launching Lynparza for mCRPC patients by introducing and implementing HRR testing, establishing it as a standard practice for optimizing treatment in mCRPC cases.

*Project coordinator in Oncolympics handling the registration and videography of 7 universities competing in an oncology science competition.

*Organized and managed over 10 high-profile oncology events and seminars, attracting more than 500 participants enhancing product visibility.

*Achieving the highest number of HRR genetic testing in my territory.

*SFE champion 2024.

*Successfully expanded Betaferon share in key regions by identifying and establishing partnerships with over 40 new healthcare providers.

*Conducted 15 training sessions and workshops for healthcare professionals on Betaferon, enhancing product knowledge.

*Implemented patient awareness campaigns contributing a significant rise in new patients rates within major state expense.

*Increasing product visibility and boosting sales in my assigned territory.

*Organized and facilitated monthly 5+ product online training workshops for healthcare professionals during covid.

*Brand Idol 2019.

*Best achiever YTD 2019.

*Team's monthly sales forecast delegate.

March 2015 - Jan 2018

*Spearheaded the introduction of respiratory new medical products across major institutions.

*Created and delivered training materials for over 100 physicians and nurses, resulting in an increase in product adoption and usage.

*Rolled out a patient screening program that enhanced diagnosis accuracy by 30%, significantly improving clinical practices.

*Ranked as the top achiever YTD 2017

January 2018 - August 2018

*Worked as a PHI specialist for (diabetes, hypertension, heart failure, bone and pain) and led initiatives that improved healthcare access for over 5,000 underserved patients, resulting in a 20% increase in treatment adherence within targeted communities.

*Collaborated with more than 30 key public health stakeholders and organizations, via activities that reached 500 site doctors,